Tian Sun

Tian Sun

Auto-generated profile, based on publicly available information

Tian Sun

Department of Immunology, Faculty of Medicine, University of Toronto , Toronto, Ontario M5S1A8

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TSTian Sun
Tian Sun
ANAlbert Nguyen
Albert Nguyen
JGJennifer L. Gommerman
Jennifer L. Gommerman
The mammalian intestine is a complex environment that is constantly exposed to Ags derived from food, microbiota, and metabolites. Intestinal dendritic cells (DC) have the responsibility of establishing oral tolerance against these Ags while initiating immune responses against mucosal pathogens. We now know that DC are a heterogeneous population of innate immune cells composed of classical and monocyte-derived DC, Langerhans cells, and plasmacytoid DC. In the intestine, DC are found in organized lymphoid tissues, such as the mesenteric lymph nodes and Peyer’s patches, as well as in the lamina propria. In this Brief Review, we review recent work that describes a division of labor between and collaboration among gut DC subsets in the context of intestinal homeostasis and inflammation. Understanding relationships between DC subtypes and their biological functions will rationalize oral vaccine design and will provide insights into treatments that quiet pathological intestinal inflammation.

6 December 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
CLConglei Li
Conglei Li
ELEvelyn Lam
Evelyn Lam
CPChristian Perez-Shibayama
Christian Perez-Shibayama
LWLesley A. Ward
Lesley A. Ward
JZJianbo Zhang
Jianbo Zhang
JGJennifer L. Gommerman
Jennifer L. Gommerman
Early-life LTβR signaling programs the mesenteric lymph node stromal cell environment, optimizing gut IgA responses in the adult mouse.

23 December 2019 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
ZCZhanhong Chen
Zhanhong Chen
TSTian Sun
Tian Sun
ZYZiyan Yang
Ziyan Yang
YZYabing Zheng
Yabing Zheng
RYRuoying Yu
Ruoying Yu
XWXiaojia Wang
Xiaojia Wang
Background: One of the major challenges in managing invasive breast cancer (BC) is the lack of reliable biomarkers to track response. Circulating tumor DNA (ctDNA) from liquid biopsy, as a candidate biomarker, provides a valuable assessment of BC patients. In this retrospective study, we evaluated the utility of ctDNA to reflect the efficacy of treatment and to monitor resistance mechanisms.Methods: Targeted next‐generation sequencing (NGS) of 416 cancer‐relevant genes was performed on 41 plasma biopsy samples of 19 HER2+ and 12 HER2‐ BC patients. Longitudinal ctDNA samples were analyzed in three BC patients over the treatment course for detecting acquired mutations.Results: In HER2+ BC patients, ERBB2 somatic copy numbers in ctDNA samples were significantly higher in patients progressed on HER2‐targeted therapy than those who were still responding to the treatment. Recurrent acquired mutations were detected in genes including ERBB2, TP53, EGFR, NF1, and SETD2, which may contribute to trastuzumab resistance. In longitudinal analyses, the observed mutation allele frequencies were tracked closely in concordance with treatment responses. A novel ERBB2 p.(Leu869Arg) mutation was acquired in one patient upon resistant to trastuzumab therapy, which was further validated as an oncogenic mutation in vitro and contributed to resistance. In HER2‐ BC patients with chemotherapy resistance, genetic alterations on TP53, PIK3CA, and DNA damage repair genes were frequently observed.Conclusions: In summary, ctDNA monitoring, particularly longitudinal analyses, provides valuable insights into the assessment of targeted therapy efficacy and gene alterations underlying trastuzumab resistance and chemotherapy resistance in HER2+ and HER2‐ BC patients, respectively.

11 July 2017
Verified
Dataset
Closed access
JGJennifer Gommerman
Jennifer Gommerman
TSTian Sun
Tian Sun
In this study, the authors show that NLRP9b, a novel Nod-like receptor (NLR) expressed specifically in intestinal epithelial cells (IEC), is important for restricting rotavirus infection in suckling mice. They also demonstrate that, through its interaction with RNA helicase DHX9, NLRP9b recognizes short double-stranded RNA stretches and forms inflammasome complexes with the adaptor protein ASC and Caspase-1 to promote both the secretion of interleukin (IL)-18, as well as gasdermin D-driven pyroptosis. In the context of rotavirus infection, pyroptosis of infected IEC is required for viral control. The mechanism for this is that, as the infected IEC undergoes pyroptosis, this exposes the virus to local phagocytes. Although the IEC dies, this might nevertheless represent an evolutionary strategy to deal with intracellular pathogens. In terms of the IL-18 response in the context of Rotavirus infection, this is partially dependent on the NLRP9b inflammasome, suggesting other NLR family members, such as NLRP6 (which is also highly expressed in IEC), might contribute as well. In the future, it will be interesting to define the role of NLRP9b in anti-rotavirus infection in adult mice in order to learn more about this novel mechanism of host protection.